BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8103103)

  • 1. Pharmacological properties of beta-amyrin palmitate, a novel centrally acting compound, isolated from Lobelia inflata leaves.
    Subarnas A; Tadano T; Oshima Y; Kisara K; Ohizumi Y
    J Pharm Pharmacol; 1993 Jun; 45(6):545-50. PubMed ID: 8103103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A possible mechanism of antidepressant activity of beta-amyrin palmitate isolated from Lobelia inflata leaves in the forced swimming test.
    Subarnas A; Tadano T; Nakahata N; Arai Y; Kinemuchi H; Oshima Y; Kisara K; Ohizumi Y
    Life Sci; 1993; 52(3):289-96. PubMed ID: 8423710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An alpha-adrenoceptor-mediated mechanism of hypoactivity induced by beta-amyrin palmitate.
    Subarnas A; Tadano T; Kisara K; Ohizumi Y
    J Pharm Pharmacol; 1993 Nov; 45(11):1006-8. PubMed ID: 7908030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An antidepressant principle of Lobelia inflata L. (Campanulaceae).
    Subarnas A; Oshima Y; Sidik ; Ohizumi Y
    J Pharm Sci; 1992 Jul; 81(7):620-1. PubMed ID: 1403691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Behavioral pharmacological properties of the novel antidepressant paroxetine, a selective 5-HT uptake inhibitor].
    Yamamoto T; Shibata S; Shimazoe T; Iwasaki K; Ohno M; Minamoto Y; Furuya Y; Miyamoto K; Watanabe S; Ueki S
    Nihon Yakurigaku Zasshi; 1989 Sep; 94(3):189-206. PubMed ID: 2530142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavioral pharmacology of a new antidepressant, lopramine].
    Ueki S; Fujiwara M; Inoue K
    Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):585-607. PubMed ID: 1033109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some behavioral effects of 1,3-di-o-tolylguanidine, opipramol and sertraline, the sigma site ligands.
    Maj J; Rogóz Z; Skuza G
    Pol J Pharmacol; 1996; 48(4):379-95. PubMed ID: 9112678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological comparison of the potential antidepressant UP 614-04 with viloxazine and imipramine; behavioral studies.
    Meignen J; Grognet A; Deniard MJ; Dalphrase F; Roux E; DeFeudis FV
    Gen Pharmacol; 1982; 13(5):381-91. PubMed ID: 6890919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Behavioral pharmacology of mianserin hydrochloride, a new antidepressant (author's transl)].
    Kamioka T; Sakai Y
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):533-47. PubMed ID: 7193623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior pharmacology of maprotiline, a new antidepressant].
    Ueki S; Fujiwara M; Inoue K; Kataoka Y; Ibii N
    Nihon Yakurigaku Zasshi; 1975 Nov; 71(8):789-815. PubMed ID: 1240830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of MK-801 and antidepressant drugs in the forced swimming test in rats.
    Maj J; Rogóz Z; Skuza G; Sowińska H
    Eur Neuropsychopharmacol; 1992 Mar; 2(1):37-41. PubMed ID: 1638172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
    Worms P; Kan JP; Wermuth CG; Roncucci R; Bizière K
    J Pharmacol Exp Ther; 1987 Jan; 240(1):241-50. PubMed ID: 3100770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioural profile of two potential antidepressant pyridazine derivatives including arylpiperazinyl moieties in their structure, in mice.
    Rubat C; Coudert P; Bastide P; Tronche P
    J Pharm Pharmacol; 1995 Feb; 47(2):162-70. PubMed ID: 7602473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological properties of MO-8282, a novel antidepressant].
    Niho T; Ito C; Shibutani Y; Hashizume H; Yamaguchi K
    Nihon Yakurigaku Zasshi; 1986 Oct; 88(4):309-20. PubMed ID: 3792961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of repeated administration of imipramine, citalopram and mianserin on responsiveness of central serotonergic, alpha 2-adrenergic and cholinergic system in mice.
    Maj J; Rogóz Z; Skuza G; Sowińska H
    Pol J Pharmacol Pharm; 1989; 41(4):313-9. PubMed ID: 2561380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative importance of the dopaminergic system in haloperidol-catalepsy and the anticataleptic effect of antidepressants and methamphetamine in rats.
    Al-Khatib IM; Fujiwara M; Ueki S
    Pharmacol Biochem Behav; 1989 May; 33(1):93-7. PubMed ID: 2528750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressant effect of an ethanolic extract of the leaves of Cissampelos sympodialis in rats and mice.
    Almeida RN; Navarro DS; de Assis TS; de Medeiros IA; Thomas G
    J Ethnopharmacol; 1998 Dec; 63(3):247-52. PubMed ID: 10030729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavioral effects of a new antidepressant, setiptiline].
    Yamada K; Furukawa T
    Nihon Yakurigaku Zasshi; 1991 Jan; 97(1):31-9. PubMed ID: 2045013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Withania somnifera on forced swimming test induced immobility in mice and its interaction with various drugs.
    Shah PC; Trivedi NA; Bhatt JD; Hemavathi KG
    Indian J Physiol Pharmacol; 2006; 50(4):409-15. PubMed ID: 17402272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the central properties of several Hypericum species from the Canary Islands.
    Prado B; Rabanal RM; Sánchez-Mateo CC
    Phytother Res; 2002 Dec; 16(8):740-4. PubMed ID: 12458477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.